A team of experts from the University of Glasgow will lead a new international effort to improve cancer control and reduce global health inequalities. Spearheading the new Lancet Oncology Commission focused on cancer genomics and precision oncology, University of Glasgow researchers will lead an international team of experts over the next two years to create a blueprint for overcoming barriers and improving global access to the most innovative diagnostic tests and personalised cancer care. The newly formed commission will start by examining some of the biggest challenges faced by healthcare systems and cancer clinicians worldwide for the widespread adoption of
University of Glasgow to lead international effort to advance cancer care and research as seen on The Hippocratic Post.